Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pre-Injection Iopidine on IOP and Vision Loss Following Intravitreal Injections
NCT07891910Phase 4Not yet recruiting
- Sponsor
- Retina Consultants of Delmarva
- Start
- Oct 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 4 trial of apraclonidine in ocular hypertension, transient vision loss (TVL), sponsored by Retina Consultants of Delmarva. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
apraclonidine
03
Conditions
ocular hypertensiontransient vision loss (TVL)
Beyond the preview
Go deeper on NCT07891910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07891910.